U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2003
181
Substance Class Protein
Created
by admin
on Mon Mar 31 18:01:32 GMT 2025
Edited
by admin
on Mon Mar 31 18:01:32 GMT 2025
Protein Type ENZYME
Protein Sub Type IDURONIDASE
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
WP58SVM6R4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALRONIDASE
Preferred Name English
LARONIDASE
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Common Name English
LARONIDASE [PURPLE BOOK CDER]
Common Name English
LARONIDASE [JAN]
Common Name English
ALDURAZYME
Brand Name English
EC 3.2.1.76
Common Name English
LARONIDASE [MI]
Common Name English
Laronidase [WHO-DD]
Common Name English
IDURONIDASE, ALPHA-L- (HOMO SAPIENS)
Common Name English
LARONIDASE [EMA EPAR]
Common Name English
laronidase [INN]
Common Name English
LARONIDASE [USAN]
Common Name English
LARONIDASE [MART.]
Common Name English
LARONIDASE [VANDF]
Common Name English
Classification Tree Code System Code
NDF-RT N0000167711
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
NDF-RT N0000175823
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
WHO-ATC A16AB05
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
WHO-VATC QA16AB05
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
EMA ASSESSMENT REPORTS ALDURAZYME (AUTHOURIZED: MUCOPOLYSACCHARIDOSIS I)
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
EU-Orphan Drug EU/3/01/022
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
FDA ORPHAN DRUG 106097
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
NCI_THESAURUS C29726
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
Code System Code Type Description
USAN
LL-41
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
EVMPD
SUB20048
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
SMS_ID
100000089543
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
DRUG BANK
DB00090
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
MERCK INDEX
m6205
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY Merck Index
DAILYMED
WP58SVM6R4
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
DRUG CENTRAL
4997
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
RXCUI
392509
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY RxNorm
CAS
210589-09-6
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
WIKIPEDIA
Iduronidase
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
INN
8015
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
LACTMED
Laronidase
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
FDA UNII
WP58SVM6R4
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
NCI_THESAURUS
C83864
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201595
Created by admin on Mon Mar 31 18:01:32 GMT 2025 , Edited by admin on Mon Mar 31 18:01:32 GMT 2025
PRIMARY
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_85
N 1_165
N 1_311
N 1_357
N 1_390
N 1_426
Related Record Type Details
LARONIDASE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966